Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

Industry Trends

Clinical Trial Trends

Disease Area Trends

Recent Tweets

$CRMD CorMedix Inc. reveals that CMS has awarded TDAPA to DefenCath.

More Info: https://pryzm.ozmosi.com/product/2121 $XBI $IBB $XPH $PPH

$OCGN Ocugen completes dosing of subjects with Geographic Atrophy in Phase 1/2 ArMaDa trial of OCU410 gene therapy modifier.

More Info: https://pryzm.ozmosi.com/product/27030 $XBI $IBB $XPH $PPH

FDA approves GenFleet Therapeutics' GFH925 for Phase III study on treating metastatic colorectal cancer with KRAS G12C inhibitor monotherapy.

More Info: https://pryzm.ozmosi.com/product/26990 $XBI $IBB $XPH $PPH

$MRK Health Canada has approved KEYTRUDA® for adult patients with advanced gastric or GEJ adenocarcinoma in combination with chemotherapy containing fluoropyrimidine and platinum.

More Info: https://pryzm.ozmosi.com/product/6714 $XBI $IBB $XPH $PPH

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762